NEXTGENPCR: 30 cycli, 3 temperatures, less than 2 minutes

CALL US: +31 113 268110
Category

NEXTGENPCR

Molecular Biology Systems and Velocidy Bio sign distribution agreement.

NEXTGENPCR, the ultrafast PCR system, is now available in the United States and Canada.

Goes, Netherlands, Feb. 19, 2020

Molecular Biology Systems (MBS), the developer of NEXTGENPCR, is pleased to announce their newest distributor, Velocidy Bio. Velocidy Bio becomes the exclusive distributor of NEXTGENPCR instruments, accessories and consumables in the United States and Canada. NEXTGENPCR is an innovative thermal cycler that can reduce cycling programs to less than two minutes, by both eliminating ramp times as well as reducing dwell times.

“NEXTGENPCR is an innovative solution that accelerates nucleic acid amplification, so we identify special commercial partners that will support users as they adopt our system.” states Gert de Vos, Founder and CEO of Molecular Biology Systems. “We look forward to working with Velocidy Bio, an innovative distributor focused on improving the laboratory experience by accelerating protocols.”

The NEXTGENPCR’s design does not disrupt current laboratory workflows, instead it accelerates the cycling protocol. Therefore, the NEXTGENPCR system has been widely adopted across laboratory segments including public and private research and testing labs in academia, government, biotech and pharmaceutical. Since launching two years ago, MBS has increasing the rate of NEXTGENPCR placements.

The NEXTENPCR instrument, accessories, and consumables are now available in the United States and Canada for purchase through Velocidy Bio at www.velocidybio.com. For other countries, please see Molecular Biology Systems’ commercial partners at www.nextgenpcr.com/buy-nextgen-pcr/

About Molecular Biology Systems

Molecular Biology Systems B.V. is a Netherlands company that developed and commercialized NEXTGENPCR, a universal ultrafast PCR system. The NEXTENPCR instrument uses an innovative temperature control method during cycling, which eliminates ramp time. Molecular Biology Systems offers their NEXTGENPCR instrument, accessories and consumables around the world, to laboratories in life science research, pharmaceutical and biotechnology companies, forensics, veterinary testing and food safety. Further information can be found at www.nextgenpcr.com.

About Velocidy Bio, Inc.

Velocidy Bio is focused on delivering solutions that decrease time-to-results for biological laboratories. Working together with innovative organizations, Velocidy Bio offers solutions globally that reduce protocols from hours to minutes. These accelerated protocols enable scientists to increase their productivity and reduce stress associated with delays in generating results.  Initially, Velocidy Bio is focused on reducing the time required to extract, amplify and analyze nucleic acids. Further information can be found at www.velocidybio.com.

 

Please follow and like us:
error
fb-share-icon
Tweet

See 2 minute PCR at the ASHG

Molecular Biology Systems will be exhibiting at this year’s American Society of Human Genetics Conference from October 15-19, 2019 in Houston, USA. MBS is looking forward to meeting those attending. To learn more about NextGenPCR, stop by Booth 107 any time during the exhibit.

MBS introduces NextGenPCR. Using SBS-plate format a 100bp fragment can be amplified in 2 minutes (30 cycles, 3 temperatures). Longer fragments take slightly longer, but will still be amplified in minutes rather than hours. This versatile system lets you run 96-well plates and 384-well plates without changing blocks. Volumes range from 3 to 50 microliters. The technology has proven to work over a wide range of application.


For more information about American Society of Human Genetics Conference 2019, visit their website.

We hope to see you in Houston, USA!

 

Please follow and like us:
error
fb-share-icon
Tweet

Base location: Netherlands (preferred)

Molecular Biology Systems (MBS) have developed an industry-leading PCR platform focused on time-to-result. We are seeking candidates with sales management and distribution experience to manage the company’s distributor network in Europe/Middle East/Asia as we grow. This is a fantastic opportunity with enormous potential!

Responsibilities:

  • Manage international distribution sales network, review territories, set sales forecasts and ensure revenue targets are achieved.
  • Prioritise markets and determine market entry strategies for new regions.
  • Establish and lead regular meetings and conference calls with distributors.
  • Train distributors to ensure continual improvement in product knowledge and customer service. Prepare monthly and quarterly reports, and sales forecasts.
  • Develop and maintain relationships with key customers in each distributor territory.
  • Manage and attend trade-show exhibitions.
  • Support voice-of-customer research.
  • Significant international travel required.

Qualifications:

  • Degree or Training in Molecular Biology (or similar); PCR/qPCR experience preferred.
  • 3 years life science sales/sales management experience required.
  • International distribution experience preferred.
  • Strong communication and presentation skills; able to motivate distributor teams and effectively engage with customers.
  • Ability to develop training programs for distributors.
  • Excellent time management and organisational skills.

Offered:

  • Good compensation, including a bonus scheme.
  • Room for personal growth.
  • Pleasant working environment.
  • The opportunity to grow in international business.

Send your email to:

gertdevos@mbspcr.com

Please follow and like us:
error
fb-share-icon
Tweet

JULY
Webinar on NextGenPCR by Gert de Vos (founder & CEO of MBS) still available for viewing

Until now PCR instruments have relied on Peltier elements to heat and cool an aluminum or silver block, accommodating 96 or 384 polypropylene tubes, holding PCR-mixes. Using this technology PCR times, for 30 cycle, 3-temperature reactions, are usually between 50 and 150 minutes. Now, NEXTGENPCR is redefining fast. The thermocycler introduces a new way to heat and cool the samples instantly, with virtually no ramp rates, losing no time getting the samples to the desired temperature.

The user can go from melting to annealing in less than 0.1 second. For a 100 base pair fragment, total reaction time is as low as 2 minutes, with 700 base pairs being amplified in 10 minutes. Adding NEXTGENPCR into workflows results in higher sample throughput. Using optimized applications, more than 10 full plate experiments per hour become possible. Operated at capacity this would mean 80, 384-well plates per day, resulting in more than 30,000 datapoints per day; far beyond the capabilities of common thermocyclers.

Gert held a live presentation about the NextGenPCR on May 31st. During the presentation, Gert has focused on the technology behind NEXTGENPCR. Special attention has paid to publications detailing 2 minute PCR data and how NEXTGENPCR amplified all 29 fragments of the BRCA1 gene in less than 10 minutes for subsequent Sanger sequencing.
The video is still possible to view. To watch the video, please click on the link below and register.

 

REGISTER AND VIEW NOW

The webinar is sponsored by our distributor in the US and Canada: Canon Biomedical

 

 

 

Please follow and like us:
error
fb-share-icon

Tweet

May 31st, 10:00 am ET

Until now PCR instruments have relied on Peltier elements to heat and cool an aluminum or silver block, accommodating 96 or 384 polypropylene tubes, holding PCR-mixes. Using this technology PCR times, for 30 cycle, 3-temperature reactions, are usually between 50 and 150 minutes. Now, NEXTGENPCR is redefining fast. The thermocycler introduces a new way to heat and cool the samples instantly, with virtually no ramp rates, losing no time getting the samples to the desired temperature.

The user can go from melting to annealing in less than 0.1 second. For a 100 base pair fragment, total reaction time is as low as 2 minutes, with 700 base pairs being amplified in 10 minutes. Adding NEXTGENPCR into workflows results in higher sample throughput. Using optimized applications, more than 10 full plate experiments per hour become possible. Operated at capacity this would mean 80, 384-well plates per day, resulting in more than 30,000 datapoints per day; far beyond the capabilities of common thermocyclers.

During the presentation, Gert will focus on the technology behind NEXTGENPCR. Special attention will be paid to publications detailing 2 minute PCR data and how NEXTGENPCR amplified all 29 fragments of the BRCA1 gene in less than 10 minutes for subsequent Sanger sequencing.

 

REGISTER NOW

The webinar is sponsored by: our distributor in the US and Canada: Canon Biomedical

 

 

Please follow and like us:
error
fb-share-icon

Tweet

Following a successful debut last year, we will again be present at the Festival of Genomics, London to be held January 30-31 in the ExCeL Centre.

Come at visit us on stand D5 and see the latest version of our super fast NEXTGENPCR thermal cycler which slashes PCR reaction times to between 2 and 10 minutes.

Now available across Europe through our growing network of distributors, we appear to have struck a chord with you and your fellow scientists looking to save precious time on this tedious yet essential task.

Please follow and like us:
error
fb-share-icon

Tweet

Strong demand predicted across all life science markets

Dutch biotechnology company Molecular Biology Systems(MBS) today announced it will launch its revolutionary NEXTGENPCR thermal cycler through AMPLITECH, an independent commercial organization offering innovative solutions to the public and private in vitro diagnostic testing market, including cytogenetics, molecular genetics, and pathology labs, in France, Belgium, Luxembourg, and Switzerland.

 

Read the whole article: MBS Selects CAMLAB To Launch NEXTGENPCR In UK At Lab Innovations

Please follow and like us:
error
fb-share-icon

Tweet

Strong demand predicted across all life science markets

Dutch biotechnology company Molecular Biology Systems(MBS) today announced will launch its revolutionary NEXTGENPCR thermal cycler through CAMLAB, the UK’s leading independent scientific instrumentation distributor. First showing will be at the upcoming Lab Innovations at Birmingham NEC, Nov 1-2. The UK remains a key market for the life sciences, with continuing public and private infrastructure investment – including the recently announced £146 million from the Industrial Strategy Challenge Fund.

 

Read the whole article: MBS Selects CAMLAB To Launch NEXTGENPCR In UK At Lab Innovations

Please follow and like us:
error
fb-share-icon

Tweet
Patented technology

 

Privacy Statement

MBS Molecular Biology Systems • Copyright 2017. All Rights Reserved. • Tel: +31 113 268110 • Email: info@mbspcr.com